Jun-Qi Zhu

ORCID: 0000-0001-9135-0505
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Intraperitoneal and Appendiceal Malignancies
  • Adrenal and Paraganglionic Tumors
  • Antibiotic Resistance in Bacteria
  • Pesticide and Herbicide Environmental Studies
  • Pharmaceutical and Antibiotic Environmental Impacts
  • Bacterial Identification and Susceptibility Testing
  • Weed Control and Herbicide Applications
  • Hormonal Regulation and Hypertension
  • Antibiotics Pharmacokinetics and Efficacy
  • Environmental Toxicology and Ecotoxicology
  • Antibiotic Use and Resistance
  • Metabolomics and Mass Spectrometry Studies
  • Pneumonia and Respiratory Infections
  • Ferroptosis and cancer prognosis
  • Advanced Chemical Sensor Technologies
  • Cancer-related gene regulation
  • Bladder and Urothelial Cancer Treatments
  • Biocrusts and Microbial Ecology
  • Cancer-related Molecular Pathways
  • Immune cells in cancer
  • Pancreatic and Hepatic Oncology Research
  • Lung Cancer Research Studies
  • Infections and bacterial resistance
  • Inflammasome and immune disorders
  • Bacterial biofilms and quorum sensing

Nanchang University
2023-2025

Guangxi University
2023-2025

First Affiliated Hospital of Jiangxi Medical College
2024-2025

Tongde Hospital of Zhejiang Province
2025

Second Affiliated Hospital of Nanchang University
2023-2024

Zhejiang Chinese Medical University
2019-2022

Beijing University of Chemical Technology
2018

Flusulfinam, a novel chiral herbicide, effectively controls Echinochloa crusgalli and Digitaria sanguinalis in paddy fields, indicating significant potential for practical agricultural applications. However, limited information is available on flusulfinam from perspective. A comprehensive evaluation of the enantiomeric levels was performed.

10.1002/ps.8251 article EN Pest Management Science 2024-06-21

Background:This retrospective study was designed to assess risk factors for increased 30-day mortality from bacteremia caused by Escherichia coli or Klebsiella pneumoniae and calculate the optimal point of time patients move inappropriate empirical antimicrobial therapy appropriate treatment. Material/Methods:This analyzed data 610 with a diagnosis E. coli-and K. pneumoniae-induced collected between 2020 2023, including population-based information, infection bacteria, comorbidities,...

10.12659/msm.945569 article EN cc-by-nc-nd Medical Science Monitor 2025-01-20

Indole, a crucial bacterial signaling molecule, plays fundamental role in regulating various physiological processes within bacteria, including growth, acid tolerance, biofilm development, motility, and other cellular functions. Its regulatory influence extends beyond indole-producing significantly impacting the activities non-indole-producing species. In this study, we demonstrate that indole enhances pathogenicity viability of Klebsiella pneumoniae using Galleria mellonella infection model...

10.3389/fcimb.2025.1546991 article EN cc-by Frontiers in Cellular and Infection Microbiology 2025-02-03

Introduction The tumor immune environment and immune-related genes are instrumental in the development, progression, prognosis of bladder cancer (BLCA). This study sought to pinpoint key influencing BLCA decipher their mechanisms action. Methods results We analyzed differentially expressed (DEGs) between high- low- mutational burden (TMB) groups. Subsequently, we constructed a reliable prognostic model based on gene pairs (IRGPs) DEGs low-risk A total 22 shared were identified across...

10.3389/fonc.2023.1229227 article EN cc-by Frontiers in Oncology 2024-02-29

This study aimed to identify carbapenem-resistant Klebsiella pneumoniae (CRKP) based on changes in levels of its volatile organic compounds (VOCs) simulated blood cultures (BCs) using the gas chromatography-ion mobility spectrometry (GC-IMS) technique. A comprehensive analysis metabolites produced by (K. pneumoniae) BC bottles was conducted GC-IMS. Subsequently, released VOCs were analyzed examine differences VOC release between CRKP and carbapenem-susceptible (CSKP). total 54 detected,...

10.1186/s13568-024-01708-1 article EN cc-by AMB Express 2024-04-24

Objective: This research aimed to analyze the clinical characteristics, prognosis, and antimicrobial treatment of bloodstream infections (BSI) caused by Enterobacter cloacae complex (ECC). Methods: The data patients with from April 2017 June 2023 were collected retrospectively. These then analyzed in subgroups based on detection results extended-spectrum β-lactamase (ESBL), 30-day mortality, type agent used (β-lactam/β-lactamase inhibitor combinations (BLICs) or carbapenems). Results:...

10.2147/idr.s460744 article EN cc-by-nc Infection and Drug Resistance 2024-05-01

ABSTRACT Bronchial stump fistula occurs at the site of a lobectomy or segmentectomy and is specific type bronchopleural fistula. In addition to complications such as empyema pneumothorax, large bronchial can result in decreased lung ventilation due significant air leakage, particularly during general anaesthesia with endotracheal intubation, making closure challenging. The present paper reports on case patient right who had difficulty maintaining normal oxygenation when using conventional...

10.1002/rcr2.70152 article EN cc-by-nc-nd Respirology Case Reports 2025-03-01

Abstract Most lung cancer (LC) patients are diagnosed at advanced stages due to the lack of effective screening tools. This multicenter study analyzes 1043 saliva samples (334 LC cases and 709 non‐LC cases) using a novel high‐throughput platform for metabolic fingerprint acquisition. Machine learning identifies 35 features distinguishing from subjects, enabling development classification model named SalivaMLD. In validation set test set, SalivaMLD demonstrates strong diagnostic performance,...

10.1002/advs.202416719 article EN cc-by Advanced Science 2025-05-14

Background and aim: A potent selective vascular endothelial growth factor receptor (VEGFR) inhibitor SU5416, has been developed for the treatment of solid human tumors. The binding VEGF to VEGFR plays a crucial role in pathophysiology respiratory disorders. However, impact SU5416 on lipopolysaccharide (LPS)-induced acute lung injury (ALI) remains unclear. Thus, this study aimed illuminate biofunction mouse model ALI. Methods: Wild-type (WT) toll-like 4 (TLR4)-deficient (TLR4 −/- ) C57BL/6...

10.2147/dddt.s188858 article EN cc-by-nc Drug Design Development and Therapy 2019-05-01

Objective: This research aimed to investigate the variations in clinical features and prognosis of HABP caused by E. coli K. pneumoniae . We also evaluate risk variables related 30-day death investigated groups. Methods: A single-center retrospective cohort lasting four years was performed. total 117 patients with were involved this research. The primary death. Results: Among HABP, 60 infected (KP-HABP), 57 (E. coli-HABP). higher proportion males, ICU admission, undergoing tracheotomy...

10.2147/idr.s419699 article EN cc-by-nc Infection and Drug Resistance 2023-08-01

Lactate and tumor cell-derived extracellular vesicles (TEVs) both contribute to progression. However, it is still unclear whether lactate can accelerate development by directly promoting TEV production. Here, we show that decreases intracellular cAMP levels subsequent PKA activation via GPR81, which inhibits the PKA-induced ubiquitination of HIF-1α causes degradation. Then, HIF-1α-mediated transcription Rab27a enhanced, leading increased release. In this way, promotes lung metastasis murine...

10.3389/fonc.2022.1036543 article EN cc-by Frontiers in Oncology 2022-12-01

Objective: This study aimed to determine the clinical features, risk factors, and effective antimicrobial therapy for Carbapenem-resistant Acinetobacter baumannii (CRAB) bloodstream infection (BSI). Methods: was a retrospective analysis of data from patients with CRAB bacteremia in Chinese tertiary hospital between January 2012 October 2021. Risk predictors 30-day mortality, BSI were identified using logistic cox regression analyses. Results: Data 276 (AB) included, whom 157 (56.9%) had BSI....

10.2147/idr.s408927 article EN cc-by-nc Infection and Drug Resistance 2023-05-01

To analyze the clinical characteristics, outcomes, and risk factors of patients treated with ceftazidime/avibactam, polymyxin, or tigecycline (CPT) compared those receiving a conventional therapy (CT) (ie, imipenem, levofloxacin, gentamicin).A single-center retrospective cohort study included carbapenem-resistant Klebsiella pneumoniae bloodstream infection (CRKP-BSI) at one Chinese tertiary hospital between March 2012 November 2022 was performed. Clinical CPT CT were compared. Predictors...

10.2147/idr.s409506 article EN cc-by-nc Infection and Drug Resistance 2023-05-01

<h3>Objectives:</h3> To compare the prognosis of bacteremic pneumonia caused by <i>Klebsiella pneumoniae</i> (<i>K. pneumoniae</i>) and <i>Escherichia coli</i> (<i>E. coli</i>) pathogens. <h3>Methods:</h3> A retrospective analysis was carried out on clinical data 162 patients who were diagnosed with bacterial either <i>K. or <i>E. between 2016-2019. The primary outcome patients’ 30-day mortality rate. <h3>Results:</h3> There 82 in coli</i>-BP) group 80 (KP-BP) group. rate 43.75% (n=35/80)...

10.15537/smj.2024.45.3.20230428 article EN Saudi Medical Journal 2024-03-01

Background:This study aimed to detect the volatile organic compound (VOC), 3-hydroxy-2-butanone (acetoin) using gas chromatography-ion mobility spectrometry (GC-IMS) in antimicrobial-resistant Klebsiella pneumoniae (K.pneumoniae) carbapenemase (KPC)-producing bacteria. Material/Methods:Using stromal fluid of blood culture bottles (BacT/ALERT ® SA) as medium, released by K. during growth was detected GC-IMS.The impact imipenem (IPM) and inhibitors [avibactam sodium or...

10.12659/msm.944507 article EN cc-by-nc-nd Medical Science Monitor 2024-06-27

Abstract Acquired resistance to osimertinib is inevitable and heterogeneous despite its documented efficacy against EGFR‐mutated non‐small cell lung cancer (NSCLC). Subsequent therapeutic options assume the dominant form of mechanism; however, more rare oncogenic driver, NTRK1 fusion, has also reportedly conferred resistance. Nevertheless, clear‐cut when NSCLCs are driven by EGFR mutation subsequent NTRK fusion lacking. This a case NSCLC wherein exon 19 deletion in (19del) acquired...

10.1002/rcr2.1054 article EN cc-by-nc-nd Respirology Case Reports 2022-10-17

Abstract Pseudomyxoma peritonei (PMP) is a rare malignant clinical syndrome with little known about the global mutation profile. In this study, whole-exome sequencing (WES) was performed in 49 appendiceal PMP to investigate profiles and signatures. A total of 4,020 somatic mutations were detected, median number 56 (1–402). Tumor burden (TMB) generally low (median 1.55 mutations/Mb, 0.12–11.26 mutations/Mb). Mutations mainly enriched function cancer-related axonogenesis, extracellular...

10.1158/1541-7786.mcr-22-0801 article EN Molecular Cancer Research 2023-09-28
Coming Soon ...